For the quarter ending 2026-03-31, SGMO has $59,965K in assets. $78,920K in debts. $27,586K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 27,586 | 20,948 | 29,616 | 38,344 |
| Restricted cash | - | - | 912 | - |
| Accounts receivable | 873 | 371 | 523 | 372 |
| Refundable research income tax credits | 5,491 | 10,142 | 4,602 | 4,604 |
| Prepaid expenses and other current assets | 3,164 | 4,369 | 8,423 | 6,573 |
| Total current assets | 37,114 | 35,830 | 44,076 | 49,893 |
| Restricted cash | - | 0 | 0 | 1,500 |
| Property and equipment, net | 10,317 | 11,042 | 14,794 | 15,733 |
| Operating lease right-of-use assets | 2,905 | 3,064 | 14,428 | 15,061 |
| Refundable research income tax credits, non-current | 8,759 | 8,938 | 14,474 | 14,481 |
| Other non-current assets | 870 | 871 | 871 | 890 |
| Total assets | 59,965 | 59,745 | 88,643 | 97,558 |
| Accounts payable | 19,307 | 14,437 | 15,556 | 10,740 |
| Accrued compensation and employee benefits | 18,341 | 17,721 | 17,145 | 15,425 |
| Other accrued liabilities | 15,084 | 9,409 | 9,868 | 13,938 |
| Deferred revenues | 402 | 899 | 7,556 | 7,556 |
| Total current liabilities | 53,134 | 42,466 | 50,125 | 47,659 |
| Deferred revenues, non-current | 5,874 | 5,874 | 5,874 | 5,874 |
| Long-term portion of lease liabilities | 19,332 | 25,093 | 25,424 | 23,461 |
| Other non-current liabilities | 580 | 580 | 977 | 962 |
| Total liabilities | 78,920 | 74,013 | 82,400 | 77,956 |
| Preferred stock | 0 | - | 0 | 0 |
| Common stock | 4,143 | 3,507 | 3,220 | 2,728 |
| Additional paid-in capital | 1,637,659 | 1,610,938 | 1,594,298 | 1,573,233 |
| Accumulated deficit | -1,658,244 | -1,627,249 | -1,589,830 | -1,554,900 |
| Accumulated other comprehensive loss | -2,513 | -1,464 | -1,445 | -1,459 |
| Total stockholders deficit | -18,955 | -14,268 | 6,243 | 19,602 |
| Total liabilities and stockholders deficit | 59,965 | 59,745 | 88,643 | 97,558 |
SANGAMO THERAPEUTICS, INC (SGMO)
SANGAMO THERAPEUTICS, INC (SGMO)